SmarterDx Raises $50M in Series B Funding to Enhance Clinical AI for Revenue Integrity and Care Quality
SmarterDx is committed to empowering clinical documentation integrity and coding teams to capture a more accurate, complete picture of patient care, thereby enabling healthcare providers to focus on patient care rather than paperwork.
Company Name: SmarterDx
Location: NYC, NY
Sector: Healthcare Technology, AI Software
Funding Details: Raised $50M in Series B funding, bringing the total funding to $71M to date. The round was led by Transformation Capital, with participation from Bessemer Venture Partners, Flare Capital Partners, and Floodgate Fund.
Purpose of Investment: To accelerate product innovation with new clinical and financial data integrations, refine proprietary algorithms for identifying revenue and quality opportunities, and expand market reach to benefit hospitals and health systems.
Leadership: Led by CEO Dr. Michael Gao.
Product: SmarterDx specializes in clinical AI that enhances the understanding of each patient’s clinical journey, helping hospitals achieve accurate and comprehensive clinical documentation. This technology helps close the revenue integrity “differential” gap and is capable of implementing quickly, ingesting over 30,000 data points per chart, and delivering risk-free ROI.
“Our focus has always been empowering clinical documentation integrity and coding teams to capture a more accurate, more complete patient picture and enabling providers to focus on patient care rather than paperwork.” CEO, Dr. Michael Gao
Company Vision: SmarterDx is committed to empowering clinical documentation integrity and coding teams to capture a more accurate, complete picture of patient care, thereby enabling healthcare providers to focus on patient care rather than paperwork.